IPSC
Century Therapeutics Inc

616
Mkt Cap
$51.71M
Volume
501,972.00
52W High
$1.26
52W Low
$0.3418
PE Ratio
-1.79
IPSC Fundamentals
Price
$0.5577
Prev Close
$0.5916
Open
$0.5916
50D MA
$0.5511
Beta
1.41
Avg. Volume
1.51M
EPS (Annual)
-$1.61
P/B
0.27
Rev/Employee
$43,926.67
Loading...
Loading...
News
all
press releases
Why Fast-paced Mover Century Therapeutics (IPSC) Is a Great Choice for Value Investors
If you are looking for stocks that have gained strong momentum recently but are still trading at reasonable prices, Century Therapeutics (IPSC) could be a great choice. It is one of the several stocks that passed through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks·4d ago
News Placeholder
More News
News Placeholder
Century Therapeutics (NASDAQ:IPSC) CEO Buys $17,500.00 in Stock
Century Therapeutics, Inc. (NASDAQ:IPSC - Get Free Report) CEO Brent Pfeiffenberger bought 35,000 shares of the stock in a transaction that occurred on Wednesday, November 19th. The shares were...
MarketBeat·22d ago
News Placeholder
All You Need to Know About Century Therapeutics (IPSC) Rating Upgrade to Strong Buy
Century Therapeutics (IPSC) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Zacks·5mo ago
News Placeholder
Despite Fast-paced Momentum, Century Therapeutics (IPSC) Is Still a Bargain Stock
Century Therapeutics (IPSC) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks·5mo ago
News Placeholder
Century Therapeutics (IPSC) Is Attractively Priced Despite Fast-paced Momentum
Century Therapeutics (IPSC) made it through our 'Fast-Paced Momentum at a Bargain' screen and could be a great choice for investors looking for stocks that have gained strong momentum recently but are still trading at reasonable prices.
Zacks·6mo ago
News Placeholder
Fast-paced Momentum Stock Century Therapeutics (IPSC) Is Still Trading at a Bargain
Zacks·6mo ago
News Placeholder
Century Therapeutics, Inc. (IPSC) Q1 Earnings and Revenues Top Estimates
Zacks·7mo ago
News Placeholder
Journey Medical Corporation (DERM) Reports Q1 Loss, Tops Revenue Estimates
Zacks·7mo ago
News Placeholder
Verrica Pharmaceuticals Inc. (VRCA) Reports Q1 Loss, Tops Revenue Estimates
Zacks·7mo ago

Latest IPSC News

View

Advertisement|Remove ads.

Advertisement|Remove ads.